N-Methylcyclopentane-1,2-dicarboximide | 71099-01-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-Methylcyclopentane-1,2-dicarboximide
• 英文别名: 2-methyl-tetrahydro-cyclopenta[c]pyrrole-1,3-dione；2-methyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[c]pyrrole-1,3-dione
• CAS: 71099-01-9
• 化学式: C₈H₁₁NO₂
• 分子量: 153.181
• InChiKey: KGIXYBHHLHNOGP-UHFFFAOYSA-N

物化性质

• 沸点：
  135-142 °C(Press: 20 Torr)
• 密度：
  1.206±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-Methylcyclopentane-1,2-dicarboximide 以 乙腈 为溶剂， 反应 8.0h， 以51%的产率得到N-methylcyclopentane-1,1-dicarboximide
  参考文献：
  名称：

  Photochemistry of aliphatic imides. Synthesis of azetidine-2,4-diones via photochemical isomerization of succinimides and N-formyl-N-methyl .alpha.,.beta.-unsaturated amides

  摘要：

  DOI：

  10.1021/jo00314a006
• 作为产物：
  描述：

  甲胺 、 1,2-环戊二甲酸酐 生成 N-Methylcyclopentane-1,2-dicarboximide
  参考文献：
  名称：

  Photochemistry of aliphatic imides. Synthesis of azetidine-2,4-diones via photochemical isomerization of succinimides and N-formyl-N-methyl .alpha.,.beta.-unsaturated amides

  摘要：

  DOI：

  10.1021/jo00314a006

文献信息

• POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP
  申请人：LUO STEVEN

  公开号：US20100004414A1

  公开（公告）日：2010-01-07

  A method for preparing a functionalized polymer, the method comprising the steps of preparing a reactive polymer and reacting the reactive polymer with an imide compound containing a protected amino group.

  一种制备功能化聚合物的方法，包括以下步骤：制备反应性聚合物，将反应性聚合物与含有受保护氨基团的酰亚胺化合物反应。
• SUBSTITUTED PHTHALAZIN-1 (2H)-ONE DERIVATIVES AS SELECTIVE INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE-1
  申请人：CADILA HEALTHCARE LIMITED

  公开号：US20150291603A1

  公开（公告）日：2015-10-15

  The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.

  本发明涉及一种新的化合物通式(I)，其立体异构体、区域异构体、互变异构体和合成中所涉及的新中间体，其药学上可接受的盐、药学上可接受的溶剂和含有它们的药物组合物。本发明还涉及一种制备新的化合物通式(I)、其立体异构体、区域异构体、互变异构体、其药学上可接受的盐、药学上可接受的溶剂、含有它们的药物组合物和合成中所涉及的新中间体的方法。
• Herbicidal amides
  申请人：FMC Corporation

  公开号：US11357230B2

  公开（公告）日：2022-06-14

  Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof wherein W, R1, J, Q1, R7, R8, Y, R9 and are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.

  公开了式 1 的化合物，包括其所有立体异构体、N-氧化物及其盐类 其中 W、R1、J、Q1、R7、R8、Y、R9 和如本文所定义。 本发明还公开了含有式 1 化合物的组合物，以及控制不良植被的方法，包括将有效量的本发明化合物或组合物与不良植被或其环境接触。
• DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1498411B1

  公开（公告）日：2013-01-16
• MARUYAMA K.; ISHITOKU T.; KUBO Y., J. AMER. CHEM. SOC., 1979, 101, NO 13, 3670-3671
  作者：MARUYAMA K.、 ISHITOKU T.、 KUBO Y.

  DOI：——

  日期：——